Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective

BACKGROUND: Effect of neoadjuvant chemotherapy (NAC) for pancreatic ductal adenocarcinoma (PDAC) has remained under investigation. We investigated its effect from a unique perspective and discussed its application. PATIENTS AND METHODS: We retrospecively analyzed consecutive 131 PDAC patients who un...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Surg Oncol
Auteurs principaux: Kurata, Yoshihiro, Shiraki, Takayuki, Ichinose, Masanori, Kubota, Keiichi, Imai, Yasuo
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7986386/
https://ncbi.nlm.nih.gov/pubmed/33752677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-021-02192-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires